This guideline is intended to provide the pathway for publishing the assessment reports for human medicinal products approved by SFDA. The published assessment report targeting health care providers and pharmaceuticals manufacturers in order to present the information of quality, safety and efficacy that is generated from the Original Assessment Report during the scientific evaluation.
Last Modified Date: 07/08/2022 - 9:30 AM Saudi Arabia Time